Skip to content
lifestyle.latabloid.com/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
DBV Technologies S.A.
DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update
October 28, 2026
DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026
October 27, 2026
DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
September 29, 2026
DBV Technologies to Participate in Upcoming September Investor Conferences
September 3, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026
September 2, 2026
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
July 30, 2026
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
May 22, 2026
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
February 13, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
February 11, 2026